Strategic Analysis of the Global Pharmaceutical Industry and Competitive Environment of AstraZeneca

Strategic Analysis of the global
pharmaceutical industry and
competitive environment of
Astra Zeneca

Contents
INTRODUCTION...........................................................................................................................1
MAIN BODY..................................................................................................................................1
1. Evaluate the UK and global pharmaceutical industry.............................................................1
2. Assess the competitive environment of AstraZeneca..............................................................6
CONCLUSION................................................................................................................................7
REFERENCES................................................................................................................................8

INTRODUCTION
Strategic management is a status quo can be described and described as utilising the
resources and belongings available within the employer to carry out and meet the set commercial
enterprise objectives and goals. It is a enormous aspect within a agency as it facilitates the
control of the corporation in growing plans in addition to guidelines and implement plan as it
should be and nicely. Strategic control allows the administration of an industrial business
enterprise undertaking to make informed determinations and expand as well as form green plans
of actions. In order to complete this assessment, AstraZeneca is taken in to consideration
(Baumgartner and Rauter, 2017). It is a British-Swedish multinational pharmaceutical and
biotechnology agency. This status quo turned into incorporated in 1999 and is established in
Cambridge, England, UK. It has a portfolio of products for main diseases in areas thinking about
oncology, cardiovascular, gastrointestinal, infection, neuroscience respiration and inflammation.
It is perhaps first-rate recognised for its engagement in growing the Oxford-AstraZeneca
COVID-19 vaccine. In order to perform this written assessment, the information regarding
external and internal business environment of global pharmaceutical industry will be defined.
Moreover, it will explain about the competitive environment of AstraZeneca.
MAIN BODY
1. Evaluate the UK and global pharmaceutical industry
The pharmaceutical enterprise is an essential area inside the UK. The tables beneath
display some key facts on the United Kingdom expenditure on drug treatments, as well as UK
jobs within the enterprise and the enterprise's contribution to the United Kingdom economic
system. A developing ailment burden, generic coverage, and proper get entry to healthcare
centers are boosting the UK healthcare marketplace; however increasing use of generics and
government charge-reducing measures to reduce expenditure are restricting similarly boom, says
studies and consulting firm Global Data (Engert, Rauter and Baumgartner, 2016). According to
the agency’s modern-day record, the United Kingdom pharmaceutical market turn out to be well
worth $24 billion in 2012 and is forecast to reach $31.7 billion via 2020, at a Compound Annual
Growth Rate (CAGR) of 3.5%. The segments that dominated the market in 2012 had been
Central Nervous System (CNS) drugs, in conjunction with cardiovascular and respiratory system
drugs.
1